Multiple myeloma is a cancerous disease arising from the bone marrow of a patient typically suffering from persistent back pain, fractures, minor trauma or bone pains despite routine treatment. It may also be detected incidentally during a health checkup or if the person is suffering from any particular disease like kidney failure or heart failure. Rarely it causes other soft tissue tumors in the body around the spine or the muscles. At times, a patient
(More)…
Download image BURLINGTON, Mass., May 14, 2013 /PRNewswire/ – Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European hematological oncologists indicate that overall survival is the factor that most influences their prescribing decisions for relapsed/refractory multiple myeloma, and that increased overall survival is associated with the highest level of unmet need. Interviewed thought leaders are optimistic that the CRd regimen— carfilzomib (Onyx Pharmaceuticals/Ono
(More)…
Surveyed U.S. Payers Demand That New Therapies Provide Significant Efficacy Benefits to Justify Cost, According to a New Report from Decision Resources BURLINGTON, Mass., May 14, 2013 /PRNewswire/ — Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European hematological oncologists indicate that overall survival is the factor that most influences their prescribing decisions for relapsed/refractory multiple myeloma, and that increased overall survival
(More)…
New therapies advance the treatment of this hematologic cancer. Multiple myeloma ranks as the second-most prevalent hematologic cancer after non-Hodgkin’s lymphoma and accounts for an estimated 10% of all cancers that affect the blood.1-3 According to the National Cancer Society, an estimated 22,350 adults will be newly diagnosed with multiple myeloma in 2013 and an estimated 10,710 deaths are expected.1,2 Pathology of Multiple Myeloma Multiple myeloma is a malignant neoplasm of plasma cells that accumulates
(More)…
Grammy Nominated Comedian Jim Gaffigan Headlines Comedy Show and Donna Zaccaro Ullman Honored with Spirit of Hope Award NEW YORK–(BUSINESS WIRE)–May 09, 2013– On Tuesday evening over 700 guests from the Tri-State area attended the annual Multiple Myeloma Research Foundation (MMRF) Laugh for Life: New York comedy event at Pier Sixty in New York City. Cat Greenleaf, host of NBC’s Talk Stoop with Cat Greenleaf, served as Master of Ceremonies and Jim Gaffigan, a Grammy
(More)…
A Bethalto woman claims she developed cancer after being exposed to benzene while living near a Shell Oil plant. Trudy Lehnen filed a lawsuit May 1 in Madison County Circuit Court against Shell Oil Company and BP Products North America. In her complaint, Lehnen claims she lived at 532 Seventh St. in Wood River from 1951 until 1974. Near Lehnen’s home lies the Wood River Refinery. At the refinery, Shell processed and stored benzene, a
(More)…
NEW YORK–(BUSINESS WIRE)–On Tuesday evening over 700 guests from the Tri-State area attended the annual Multiple Myeloma Research Foundation (MMRF) Laugh for Life: New York comedy event at Pier Sixty in New York City. Cat Greenleaf, host of NBC’s Talk Stoop with Cat Greenleaf, served as Master of Ceremonies and Jim Gaffigan, a Grammy nominated comedian, headlined the comedy show. The evening raised nearly $850,000 to support the innovative, groundbreaking initiatives of the MMRF to
(More)…
Email Newsletters and Alerts The latest news and analysis delivered to your in-box. Check the boxes below to sign up. New! To sign up for Keyword or Symbol Alerts click here. To view or change all of your email settings, visit the Email Setup Center. Article source: http://online.wsj.com/article/PR-CO-20130503-912429.html
Carman Licciardello, who was diagnosed with terminal, multiple myeloma cancer in February of this year, has experienced a spiritual uplift resulting from the overwhelming love and support of his fans. Multiple myeloma is a cancer of the blood that affects the body’s bone marrow and doctors estimated that Carman had 3-4 years left to live, according to About.com. Share This Story He decided to continue his ministry despite the diagnosis saying, “I will continue to
(More)…
Email Newsletters and Alerts The latest news and analysis delivered to your in-box. Check the boxes below to sign up. New! To sign up for Keyword or Symbol Alerts click here. To view or change all of your email settings, visit the Email Setup Center.